Lacosamide Injection
Product Images NDC 31722-203

10 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 31722-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Locosomideinjstrc (Locosomideinjstrc)

Locosomideinjstrc (Locosomideinjstrc)
Chemical structure diagram of lacosamide showing its molecular arrangement with labeled functional groups including carbonyl, methoxy, amide, and benzyl components.*
FDA Label Image

Locosomideinjfig1 (Locosomideinjfig1)

Locosomideinjfig1 (Locosomideinjfig1)
A bar graph showing seizure reduction median percentage change from baseline across three studies (Study 2, Study 3, Study 4). It compares placebo with Lacosamide treatment at various dosages. Lacosamide consistently shows higher seizure reduction percentages (ranging from 35% to 40%) than placebo (10% to 21%), with statistically significant differences indicated for all Lacosamide groups compared to placebo.*
FDA Label Image

Locosomideinjfig2 (Locosomideinjfig2)

Locosomideinjfig2 (Locosomideinjfig2)
A responder rate curve graph depicting the percent of patients on the x-axis and responder rate (improvement or worsening) on the y-axis for lacosamide intravenous injection at doses of 200 mg/day, 400 mg/day, and 600 mg/day compared to placebo. The graph shows varying improvement rates among different dosages and placebo groups based on patient response.*
FDA Label Image

Lacosamideinjfigure3 (Lacosamideinjfigure3)

Lacosamideinjfigure3 (Lacosamideinjfigure3)
A survival curve comparing the proportion of patients over time (days) between two groups: Placebo (N=121) and Lacosamide (N=118). The graph shows patient retention with Lacosamide showing a slower decline than Placebo. Annotations include a p-value of 0.001, hazard ratio (HR) of 0.548, and 95% confidence interval (CI) between 0.381 and 0.788. The number of patients at risk are listed at several time points from 0 to 170 days.*
FDA Label Image
FDA Label Image
FDA Label Image

Locosomideinjcarton1label (Locosomideinjcarton1label)

Locosomideinjcarton1label (Locosomideinjcarton1label)
Label for Lacosamide Injection, USP, 10 mg/mL (200 mg/20 mL) single-dose vial by Camber Pharmaceuticals, Inc., intended for intravenous use. The label includes dosage storage instructions, a barcode, batch coding area, contact number, manufacturing details, and usage warnings.*
FDA Label Image

Locosomideinjcartonlabel (Locosomideinjcartonlabel)

Locosomideinjcartonlabel (Locosomideinjcartonlabel)
Packaging label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Camber Pharmaceuticals, Inc. The carton contains 10 single-dose 20 mL vials. The label includes storage instructions, a barcode, NDC 31722-203-31, and manufacturer information for Camber Pharmaceuticals and Aspiro Pharma Limited.*
FDA Label Image

Locosomideinjvaillabel (Locosomideinjvaillabel)

Locosomideinjvaillabel (Locosomideinjvaillabel)
Label for Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL) intravenous injection in a 20 mL single-dose vial. The label includes dosage instructions reference, storage conditions, batch coding area, and manufacturer information indicating it is made by Aspiro Pharma Limited for PremierProRx.*
FDA Label Image

Locosomideinj200mg20ml (Locosomideinj200mg20ml)

Locosomideinj200mg20ml (Locosomideinj200mg20ml)
Packaging label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Camber Pharmaceuticals, Inc. The label indicates 10 single-dose 20 mL vials per package, with instructions for pharmacist to dispense the Medication Guide separately. Manufactured by Aspiro Pharma Limited, India. Includes storage and dosage information and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.